The US Food and Drug Administration has approved an antibody-drug conjugate for the treatment of Hodgkin lymphoma, the first approved treatment for this disease since 1977. The same drug was also approved for anaplastic large-cell lymphoma. ---Subscribe to MedNous to access this article--- Regulation & Policy Company News